CureVac N.V.
CVAC
$5.40
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 676.28% | 786.89% | 896.67% | 626.78% | 81.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 676.28% | 786.89% | 896.67% | 626.78% | 81.95% |
| Cost of Revenue | -82.63% | -53.01% | -9.07% | 13.47% | 25.81% |
| Gross Profit | 662.23% | 685.85% | 789.22% | 308.90% | -1.82% |
| SG&A Expenses | -3.17% | -22.61% | -22.28% | -10.07% | -14.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 29.73% | 29.84% | -53.30% | 50.92% | 62.68% |
| Total Operating Expenses | -21.36% | -13.26% | 1.40% | 19.51% | 22.97% |
| Operating Income | 186.40% | 183.53% | 179.62% | 83.54% | -14.22% |
| Income Before Tax | 179.37% | 177.35% | 173.63% | 80.23% | 5.04% |
| Income Tax Expenses | 1,153.72% | 3,191.59% | 14,448.48% | 23,969.41% | 16,013.10% |
| Earnings from Continuing Operations | 169.15% | 166.71% | 162.53% | 74.92% | 4.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 169.15% | 166.71% | 162.53% | 74.92% | 4.30% |
| EBIT | 186.40% | 183.53% | 179.62% | 83.54% | -14.22% |
| EBITDA | 197.73% | 195.05% | 191.89% | 88.83% | -16.33% |
| EPS Basic | 169.22% | 166.66% | 161.59% | 76.77% | 13.75% |
| Normalized Basic EPS | 195.22% | 193.00% | 216.40% | 84.67% | -33.24% |
| EPS Diluted | 168.87% | 166.31% | 161.23% | 76.56% | 13.75% |
| Normalized Diluted EPS | 196.18% | 193.25% | 216.75% | 85.01% | -32.91% |
| Average Basic Shares Outstanding | 0.26% | 0.22% | 1.59% | 5.40% | 9.71% |
| Average Diluted Shares Outstanding | 0.82% | 0.46% | 1.83% | 5.65% | 9.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |